Download Illegal Drug Use In The United Kingdom full books in PDF, epub, and Kindle. Read online free Illegal Drug Use In The United Kingdom ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Martin Plant |
| Publisher | : Oxford University Press, USA |
| Total Pages | : 255 |
| Release | : 2011 |
| Genre | : Health & Fitness |
| ISBN | : 0199544794 |
Humans have been using psychoactive (mind-altering) drugs since ancient times, and barely a day goes by without a drug related issue reaching the headlines. This book provides an accessible and lucid introduction to some of the main health and social issues related to illicit drugs and their use.
| Author | : Cameron Stark |
| Publisher | : Routledge |
| Total Pages | : 252 |
| Release | : 2018-12-20 |
| Genre | : Social Science |
| ISBN | : 0429825943 |
First published in 1999, Illegal Drug Use in the United Kingdom provides a comprehensive review of information and interventions available in drug misuse in order to inform local drug policies. In keeping with the policy documents in both Scotland and England, the volume covers the breadth of possible interventions, rather than health care alone. Separate chapters review educational, policing and counselling approaches and discuss work with special groups such as rural drug users, sex workers and club-goers. Although there are specialist textbooks on all aspects of addiction, this is the first text-book to bring together information in the framework used in the policy documents in the UK.
| Author | : National Research Council |
| Publisher | : National Academies Press |
| Total Pages | : 175 |
| Release | : 1993-02-01 |
| Genre | : Medical |
| ISBN | : 0309046270 |
As the nation's drug crisis has deepened, public and private agencies have invested huge sums of money in prevention efforts. Are the resulting programs effective? What do we need to know to make them more effective? This book provides a comprehensive overview on what we know about drug abuse prevention and its effectiveness, including: Results of a wide range of antidrug efforts. The role and effectiveness of mass media in preventing drug use. A profile of the drug problem, including a look at drug use by different population groups. A review of three major schools of prevention theory-risk factor reduction, developmental change, and social influence. An examination of promising prevention techniques from other areas of health and human services. This volume offers provocative findings on the connection between low self-esteem and drug use, the role of schools, the reality of changing drug use in the population, and more. Preventing Drug Abuse will be indispensable to anyone involved in the search for solutions, including policymakers, anti-drug program developers and administrators, and researchers.
| Author | : Vikram Patel |
| Publisher | : World Bank Publications |
| Total Pages | : 307 |
| Release | : 2016-03-10 |
| Genre | : Medical |
| ISBN | : 1464804281 |
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.
| Author | : United Nations Office on Drugs and Crime |
| Publisher | : |
| Total Pages | : 0 |
| Release | : 1901 |
| Genre | : |
| ISBN | : 9789210041744 |
The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.
| Author | : Paul Gahlinger |
| Publisher | : Penguin |
| Total Pages | : 481 |
| Release | : 2003-12-30 |
| Genre | : Health & Fitness |
| ISBN | : 1440650241 |
Does Ecstasy cause brain damage? Why is crack more addictive than cocaine? What questions regarding drugs are legal to ask in a job interview? When does marijuana possession carry a greater prison sentence than murder? Illegal Drugs is the first comprehensive reference to offer timely, pertinent information on every drug currently prohibited by law in the United States. It includes their histories, chemical properties and effects, medical uses and recreational abuses, and associated health problems, as well as addiction and treatment information. Additional survey chapters discuss general and historical information on illegal drug use, the effect of drugs on the brain, the war on drugs, drugs in the workplace, the economy and culture of illegal drugs, and information on thirty-three psychoactive drugs that are legal in the United States, from caffeine, alcohol and tobacco to betel nuts and kava kava.
| Author | : National Research Council |
| Publisher | : National Academies Press |
| Total Pages | : 124 |
| Release | : 2010-10-23 |
| Genre | : Law |
| ISBN | : 0309159342 |
Despite efforts to reduce drug consumption in the United States over the past 35 years, drugs are just as cheap and available as they have ever been. Cocaine, heroin, and methamphetamines continue to cause great harm in the country, particularly in minority communities in the major cities. Marijuana use remains a part of adolescent development for about half of the country's young people, although there is controversy about the extent of its harm. Given the persistence of drug demand in the face of lengthy and expensive efforts to control the markets, the National Institute of Justice asked the National Research Council to undertake a study of current research on the demand for drugs in order to help better focus national efforts to reduce that demand. This study complements the 2003 book, Informing America's Policy on Illegal Drugs by giving more attention to the sources of demand and assessing the potential of demand-side interventions to make a substantial difference to the nation's drug problems. Understanding the Demand for Illegal Drugs therefore focuses tightly on demand models in the field of economics and evaluates the data needs for advancing this relatively undeveloped area of investigation.
| Author | : Judith Aldridge |
| Publisher | : Routledge |
| Total Pages | : 223 |
| Release | : 2013-03-01 |
| Genre | : Psychology |
| ISBN | : 113682250X |
This book updates the progress into adulthood of the cohort of fourteen-year-olds who were recruited and tracked until they were eighteen years old. Illegal Leisure (1998) described their adolescent journeys and lifestyles, focusing on their early regular drinking and extensive ‘recreational’ drug use. This new edition revisits these original chapters, providing commentaries around them to discuss current implications of the original publication, plus documenting and discussing the group at twenty-two and twenty-seven years of age. Illegal Leisure Revisited positions the journeys of these twenty-somethings against the ever-changing backdrop of a consumption-oriented leisure society, the rapid expansion of the British night-time economy and the place of substance use in contemporary social worlds. It presents to the reader the ways in which these young people have moved into the world of work, long-term relationships and parenthood, and the resulting changes in the function and frequency of their drinking and drug-use patterns. Amid dire public health warnings about their favourite intoxicants, and with the growing criminalisation of a widening array of recreational drugs, the book revisits these young people as they continue as archetypal citizens in a risk society. The book is ideal reading for researchers and undergraduate students from a variety of fields, such as developmental and social psychology, sociology, criminology, cultural and health studies. Professionals working in criminal justice, health promotion, drugs education, harm reduction and treatment will also find this book an invaluable resource.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 171 |
| Release | : 2016-09-03 |
| Genre | : Social Science |
| ISBN | : 0309439124 |
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 483 |
| Release | : 2017-09-28 |
| Genre | : Medical |
| ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
